Matthias Alder

Matthias Alder

Chief Executive Officer bei GAIN THERAPEUTICS, INC.

Vermögen: 79 698 $ am 31.03.2024

59 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Matthias A.
Alder
is currently the President, Chief Executive Officer & Director at Gain Therapeutics, Inc. and the Chief Executive Officer & Director at GT Gain Therapeutics SA. He is also a Director at Autolus Holdings (UK) Ltd., the Alliance For Artificial Intelligence In Healthcare, the New York State Bar Association, the Virginia Bar Association, and the Zurich Bar Association.
In his former positions, Mr. Alder worked as Counsel at Ciba-Geigy Corp.
and Novartis, Inc. He served as the Secretary & Executive VP-Corporate Development at Cytos Biotechnology AG from 2013 to 2014.
Mr. Alder was a Partner at Cooley Godward LLP from 1997 to 2006 and a Partner-Life Sciences Transactions Practice at Cooley LLP from 1997 to 2006.
He also held positions as the Secretary, SVP-Administration & General Counsel at Amgen Rockville, Inc. from 2006 to 2012 and as the Executive Vice President at Sucampo Pharmaceuticals LLC in 2014.
Additionally, Mr. Alder was the Secretary, Chief Business Officer & Senior VP at Autolus Therapeutics Plc from 2017 to 2021 and the General Counsel & EVP-Corporate Development at Micromet Inc.Mr. Alder obtained his graduate degree from the University of Miami in 1990 and his graduate degree from the University of Basel in 1988.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
26.03.2024 21 140 ( 0,13% ) 79 698 $ 31.03.2024

Aktive Positionen von Matthias Alder

UnternehmenPositionBeginn
GAIN THERAPEUTICS, INC. Chief Executive Officer 20.09.2022
Zurich Bar Association Corporate Officer/Principal -
The Virginia Bar Association Corporate Officer/Principal -
Chief Executive Officer 01.09.2022
Director/Board Member -
Director/Board Member 16.05.2018
Corporate Officer/Principal -
Alle aktiven Positionen von Matthias Alder

Ehemalige bekannte Positionen von Matthias Alder

UnternehmenPositionEnde
AUTOLUS THERAPEUTICS PLC General Counsel 01.08.2018
SUCAMPO PHARMACEUTICALS, INC. General Counsel 01.03.2017
░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Matthias Alder im Detail an

Ausbildung von Matthias Alder

University of Miami Graduate Degree
University of Basel Graduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Matthias Alder im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

18

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen2
AUTOLUS THERAPEUTICS PLC

Health Technology

GAIN THERAPEUTICS, INC.

Health Technology

Private Unternehmen14
Ciba-Geigy Corp.

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Commercial Services

Commercial Services

The Virginia Bar Association

Zurich Bar Association

Health Technology

Health Technology

Technology Services

Micromet Inc.

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Matthias Alder